ALKERMES | ALKS - 負債





負債 変化する 日付
AbbVie USD 72.86B 5.36B 2026-03
Acadia Pharmaceuticals USD 50.79M 1.39M 2026-03
ALKERMES USD 1.58B 1.51B 2026-03
Amgen USD 57.32B 2.72B 2026-03
Biogen USD 8.09B 1.53B 2026-06
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Coherus Biosciences USD 294.92M 1.25M 2025-03
Eli Lilly USD 43.37B 867M 2026-03
Gilead Sciences USD 22.17B 2.76B 2026-03
Heron Therapeutics USD 149.65M 157K 2024-09
Ionis Pharmaceuticals USD 1.91B 425.5M 2026-06
J&J USD 54.99B 7.05B 2026-03
Malin Corporation EUR 100K 0 2023-12
Merck USD 49.12B 222M 2026-03
Minerva Neurosciences USD 0 0 2024-09
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 406.2M 9.1M 2026-03
Otsuka Holdings JPY 227.98B 16.47B 2025-12
Ovoca Bio EUR 0 0 2021-06
Pfizer USD 63.19B 536M 2026-06
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Vertex Pharmaceuticals USD 1.98B 8.9M 2026-06